Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Whitehawk Therapeutics (WHWK) Income from Continuing Operations (2018 - 2025)

Whitehawk Therapeutics (WHWK) has disclosed Income from Continuing Operations for 8 consecutive years, with 86799000.0 as the latest value for Q4 2025.

  • Quarterly Income from Continuing Operations rose 575.01% to 86799000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1906000.0 through Dec 2025, up 102.99% year-over-year, with the annual reading at 20596000.0 for FY2025, 67.66% up from the prior year.
  • Income from Continuing Operations for Q4 2025 was 86799000.0 at Whitehawk Therapeutics, up from 17696000.0 in the prior quarter.
  • The five-year high for Income from Continuing Operations was 86799000.0 in Q4 2025, with the low at 87088000.0 in Q3 2021.
  • Average Income from Continuing Operations over 5 years is 14907550.0, with a median of 15607500.0 recorded in 2021.
  • The sharpest move saw Income from Continuing Operations plummeted 2911.34% in 2021, then skyrocketed 575.01% in 2025.
  • Over 5 years, Income from Continuing Operations stood at 15992000.0 in 2021, then increased by 13.0% to 13913000.0 in 2022, then dropped by 16.93% to 16269000.0 in 2023, then fell by 12.32% to 18273000.0 in 2024, then surged by 575.01% to 86799000.0 in 2025.
  • According to Business Quant data, Income from Continuing Operations over the past three periods came in at 86799000.0, 17696000.0, and 52770000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.